Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

被引:72
|
作者
Cartledge, JJ
Eardley, I
Morrison, JFB
机构
[1] St Jamess Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England
[2] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates
关键词
erectile dysfunction; diabetes mellitus; advanced glycation end-products (AGEs); aminoguanidine;
D O I
10.1046/j.1464-410x.2001.00067.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine if advanced glycation products (AGEs) are responsible for the lower neuronal and endothelial-derived nitric oxide (NO)mediated relaxation of corpus cavernosum in tissue in diabetic rats than in control rats. Materials and methods Diabetes was induced in male Wistar rats by an intraperitoneal injection with streptozotocin (60 mg/kg). One group of diabetic rats was given free access to water and standard diet. A second group was given standard diet and aminoguanidine with their water (50 mg/100 mL) from the initiation of diabetes. Two groups of rats that were not diabetic acted as age-matched controls. After 8 weeks animals were killed by cervical dislocation, corpus cavernosal tissue strips harvested and in an organ bath to measure isometric After 90 min of equilibration at optimal resting tension and contraction with 1 mu mol/L noradrenaline, the response to either acetylcholine or electrical field stimulation (EFS) after adding guanethidine (5 mu mol/L) and atropine (1 mu mol/L) was determined for each group. Results There was no difference between the baseline characteristics of all the experimental groups. After 8 weeks the mean body mass and glycosylated haemoglobin (HbA(1c)) were significantly greater in the diabetic than in control animals. Aminoguanidine had no effect on the recorded body mass or HbA(1c). The in vitro relaxation response to the application of acetylcholine or EFS of tissue strips from age-matched control animals fed a standard diet and those supplemented with aminoguanidine were the same. The administration of aminoguanidine to diabetic animals for 8 weeks reversed the expected impaired relaxation response to acetylcholine; the response to EFS was similar. Conclusion AGEs are more prevalent in erectile tissue from diabetic than in control animals. Aminoguanidine reversed the impairment in neuronal and endothelial NO-mediated penile smooth muscle relaxation seen in diabetes. As aminoguanidine prevents AGE formation, erectile dysfunction in diabetes is probably caused partly by the generation of AGEs.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [21] Advanced glycation end-products in diabetes mellitus, with particular reference to angiopathy
    Chiarelli, F
    Mansour, M
    Verrotti, A
    DIABETES NUTRITION & METABOLISM, 2000, 13 (04) : 192 - 199
  • [22] Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP
    Kyung, Sun Young
    Byun, Kyung Hee
    Yoon, Jin Young
    Kim, Yu Jin
    Lee, Sang Pyo
    Park, Jeong-Woong
    Lee, Bong Hee
    Park, Jong Sook
    Jang, An Soo
    Park, Choon Sik
    Jeong, Sung Hwan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 221 - 228
  • [23] Osseous wound repair under inhibition of the axis of advanced glycation end-products and the advanced glycation end-products receptor
    Tsai, Sheng-Chueh
    Jheng, Yi-Han
    Wang, Chen-Ying
    Chen, Yi-Wen
    Lin, Yu-Fang
    Chen, Chih-Cheng
    Chang, Po-Chun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (10) : 973 - 980
  • [24] Advanced glycation end-products in diabetes mellitus and renal failure - Foreword
    Maeda, K
    Shinzato, T
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 1 - 1
  • [25] Natural inhibitors of advanced glycation end-products
    Ramkissoon, J. S.
    Mahomoodally, Fawzi M.
    Ahmed, Nessar
    Subratty, Hussein A.
    NUTRITION & FOOD SCIENCE, 2012, 42 (06): : 397 - 404
  • [26] Advanced glycation end-products in diabetic nephropathy
    Sugiyama, S
    Miyata, T
    Horie, K
    Iida, Y
    Tsuyuki, M
    Tanaka, H
    Maeda, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 : 91 - 94
  • [27] Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies
    Molinuevo, Maria Silvina
    Cortizo, Ana Maria
    Sedlinsky, Claudia
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2023, 37 (11)
  • [28] Advanced glycation end-products and peritoneal sclerosis
    Nakamura, S
    Niwa, T
    SEMINARS IN NEPHROLOGY, 2004, 24 (05) : 502 - 505
  • [29] Advanced glycation end-products in diabetic nephropathy
    Friedman, EA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 : 1 - 9
  • [30] Erratum to: Advanced glycation end-products: a review
    R. Singh
    A. Barden
    T. Mori
    L. Beilin
    Diabetologia, 2002, 45 : 293 - 293